[VYNE] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -36.43%
YoY- -131.22%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue -10,640 0 10,143 497 2,775 909 449 -
PBT -17,594 -12,847 -8,347 -12,657 -9,277 -8,172 -6,153 101.07%
Tax -11 0 0 0 -2 0 0 -
NP -17,594 -12,847 -8,347 -12,657 -9,277 -8,172 -6,153 101.07%
Tax Rate - - - - - - - -
Total Cost 6,954 12,847 18,490 13,154 12,052 9,081 6,602 3.51%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 165.36 0.00 -82.29 -2,546.68 -334.31 -899.01 -1,370.38 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -54.68 -40.26 -26.28 -51.83 -32.43 -50.99 -38.39 26.51%
EPS Diluted -54.68 -40.26 -26.28 -51.83 -32.43 -50.99 -38.39 26.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.